Scroll to top

2021 Announcements

CLINUVEL
Posted by CLINUVEL
March 1, 2021

SCIENTIFIC COMMUNIQUÉ IX

Beyond Pigment, the Melanocortin 1 Receptor (MC1R) in DNA Repair March 2021...

Read More
CLINUVEL
Posted by CLINUVEL
February 24, 2021

Operations Update Webinar

https://vimeo.com/516430955/8f3e88ca5c

Read More
CLINUVEL
Posted by CLINUVEL
February 24, 2021

CLINUVEL Reports Tenth Consecutive Half Year Net Profit

KEY HIGHLIGHTS, HALF YEAR ENDED 31 DECEMBER 2020 Consolidated Entity Result Change...

Read More
CLINUVEL
Posted by CLINUVEL
February 24, 2021

Appendix 4D Half Year Report

Results For Announcement To The Market ($A’000) Revenues from continuing activities Increased...

Read More
Jenna Reid
Posted by Jenna Reid
February 19, 2021

Financial Results Half Year Ended 31 December 2020

Operations Update I Webinar CLINUVEL PHARMACEUTICALS LTD CLINUVEL PHARMACEUTICALS LTD will host...

Read More
CLINUVEL
Posted by CLINUVEL
February 11, 2021

SCENESSE® Granted Market Access In Israel

CLINUVEL today announced that SCENESSE® (afamelanotide 16mg) has been added to the...

Read More
CLINUVEL
Posted by CLINUVEL
January 28, 2021

Kommuniqué I

Liebe Freunde, Aktionäre, Wir sind in ein neues Jahr eingetreten, eines voller...

Read More
CLINUVEL
Posted by CLINUVEL
January 28, 2021

Appendix 4C & Activity Report

Melbourne, Australia, 28 January 2021 CLINUVEL PHARMACEUTICALS LTD today announced its Appendix...

Read More
CLINUVEL
Posted by CLINUVEL
January 25, 2021

CLINUVEL Communiqué I

Dear friends, shareholders, We have entered a new year, one brimmed with...

Read More
CLINUVEL
Posted by CLINUVEL
January 12, 2021

H.C. Wainwright Bioconnect Conference 2021

12 January 2021 https://vimeo.com/clinuvel/review/499638631/b90c97ddb9 Download Presentation & Speaker Notes

Read More
We use cookies to give you the best experience.